102 Conversely, many groups are advocating to the incorporation of novel markers, for instance a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical exercise. Each one of these novel prognostic and/or predictive styles will need to be validated in cohorts of clients treated with specifi